133 related articles for article (PubMed ID: 9561405)
1. Towards the optimal antihistamine: studies with ebastine.
Roberts DJ
Inflamm Res; 1998; 47 Suppl 1():S36-7. PubMed ID: 9561405
[No Abstract] [Full Text] [Related]
2. Cardiotoxic and drug interaction profile of the second generation antihistamines ebastine and terfenadine in an experimental animal model of torsade de pointes.
Hey JA; del Prado M; Kreutner W; Egan RW
Arzneimittelforschung; 1996 Feb; 46(2):159-63. PubMed ID: 8720305
[TBL] [Abstract][Full Text] [Related]
3. Comparative effects of nonsedating histamine H1 receptor antagonists, ebastine and terfenadine, on human Kv1.5 channels.
Valenzuela C; Delpón E; Franqueza L; Gay P; Vicente J; Tamargo J
Eur J Pharmacol; 1997 May; 326(2-3):257-63. PubMed ID: 9196279
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effects of the antihistamines epinastine, terfenadine, and ebastine on potassium currents in rat ventricular myocytes.
Ohtani H; Hanada E; Hirota M; Sato H; Kotaki H; Sawada Y; Uemura H; Nakaya H; Iga T
J Pharm Pharmacol; 1999 Sep; 51(9):1059-63. PubMed ID: 10528990
[TBL] [Abstract][Full Text] [Related]
5. [Pharmacological study of ebastine, a novel histamine H1-receptor antagonist].
Yakuo I; Ishii K; Seto Y; Imano K; Takeyama K; Nakamura H; Karasawa T
Nihon Yakurigaku Zasshi; 1994 Mar; 103(3):121-35. PubMed ID: 7511558
[TBL] [Abstract][Full Text] [Related]
6. Effects of supratherapeutic doses of ebastine and terfenadine on the QT interval.
Malik M
Br J Clin Pharmacol; 2002 Dec; 54(6):682-3. PubMed ID: 12492623
[No Abstract] [Full Text] [Related]
7. Suppression of mammalian K+ channel family by ebastine.
Ko CM; Ducic I; Fan J; Shuba YM; Morad M
J Pharmacol Exp Ther; 1997 Apr; 281(1):233-44. PubMed ID: 9103502
[TBL] [Abstract][Full Text] [Related]
8. A comparison of Cetirizine, Ebastine, Epinastine, Fexofenadine, Terfenadine, and Loratadine versus placebo in suppressing the cutaneous response to histamine.
Grant JA; Danielson L; Rihoux J; DeVos C
Int Arch Allergy Immunol; 1999; 118(2-4):339-40. PubMed ID: 10224437
[No Abstract] [Full Text] [Related]
9. Computer-assisted comparison of the structural and electronic dispositions of ebastine and terfenadine.
Segarra V; López M; Ryder H; Palacios JM; Roberts DJ
Drug Saf; 1999; 21 Suppl 1():45-61; discussion 81-7. PubMed ID: 10597868
[TBL] [Abstract][Full Text] [Related]
10. A steric approach for the design of antihistamines with low muscarinic receptor antagonism.
Zhang MQ; Walczynski K; Timmerman H
Inflamm Res; 1995 Apr; 44 Suppl 1():S90-1. PubMed ID: 8521019
[No Abstract] [Full Text] [Related]
11. Comparative analysis of the cardiotoxicity proclivities of second generation antihistamines in an experimental model predictive of adverse clinical ECG effects.
Hey JA; del Prado M; Sherwood J; Kreutner W; Egan RW
Arzneimittelforschung; 1996 Feb; 46(2):153-8. PubMed ID: 8720304
[TBL] [Abstract][Full Text] [Related]
12. The guinea pig model for assessing cardiotoxic proclivities of second generation antihistamines.
Hey JA; del Prado M; Sherwood J; Kreutner W; Egan RW
Arzneimittelforschung; 1996 Aug; 46(8):834-7. PubMed ID: 9125290
[No Abstract] [Full Text] [Related]
13. Some observations on the cardiotoxic and drug interaction profiles of second generation antihistamines as measured in the guinea pig.
Roberts DJ; Llenas J
Arzneimittelforschung; 1996 Aug; 46(8):832-3. PubMed ID: 9125289
[No Abstract] [Full Text] [Related]
14. Comparative antiallergic effects of second-generation H1-antihistamines ebastine, cetirizine and loratadine in preclinical models.
Llupià J; Gras J; Llenas J
Arzneimittelforschung; 2003; 53(2):93-7. PubMed ID: 12642964
[TBL] [Abstract][Full Text] [Related]
15. Ebastine. a review of its pharmacological properties and clinical efficacy in the treatment of allergic disorders.
Wiseman LR; Faulds D
Drugs; 1996 Feb; 51(2):260-77. PubMed ID: 8808167
[TBL] [Abstract][Full Text] [Related]
16. Preclinical comparison of ebastine and other second generation H1-antihistamines.
Yakuo I; Yabuuchi M; Ito T
Pharmacol Toxicol; 2001 Oct; 89(4):171-6. PubMed ID: 11881966
[TBL] [Abstract][Full Text] [Related]
17. Effects of histamine H1 receptor antagonists on action potentials in guinea-pig isolated papillary muscles.
Ki I; Inui A; Ito T
Arch Int Pharmacodyn Ther; 1996; 331(1):59-73. PubMed ID: 8896711
[TBL] [Abstract][Full Text] [Related]
18. Dose-response relationship of the H1-histamine antagonist, ebastine, against histamine and methacholine-induced bronchoconstriction in patients with asthma.
Wood-Baker R; Holgate ST
Agents Actions; 1990 Apr; 30(1-2):284-6. PubMed ID: 1973585
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic-pharmacodynamic analysis of the arrhythmogenic potency of a novel antiallergic agent, ebastine, in rats.
Ohtani H; Sato H; Iga T; Kotaki H; Sawada Y
Biopharm Drug Dispos; 1999 Mar; 20(2):101-6. PubMed ID: 10206325
[TBL] [Abstract][Full Text] [Related]
20. Studies of nonsedative antihistamines. II. Assessment of its antihistaminic potency.
Aparicio S; Granel C; Randazzo L; Valencia M; Olivé Pérez A
Allergol Immunopathol (Madr); 1992; 20(5):207-10. PubMed ID: 1363340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
